joint pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Chief complaint of neck, shoulder, lumbar spine or knee joint pain; 2. Age 16-80, gender unlimited; 3. Those who can be included in any one of the three treatment groups as determined by the researcher; 4. Oral treatment with the following common non-steroidal anti-inflammatory drugs is required: Aryl acids: diclofenac sodium/ibuprofen/loxoprofen sodium/etocoxib; Diaryl pyrazoles: celecoxib/erecoxib; Enolates: Meloxicam. 5. Signed the informed consent voluntarily, and agreed to participate in all visits according to the requirements of the study program.
Exclusion criteria
Exclusion criteria: 1. People who are allergic to any ingredient in this product or have contact dermatitis due to the use of plasters for many times (more than three times); 2. Patients with skin damage in the affected area (can be included in screening again after the skin damage is healed); 3. Long-term use of NSAIDs in the past; 4. Known peptic ulcer; 5. Pregnant or lactating women; 6. Participated in or is participating in other researchers within three months; 7. Other circumstances that the researcher considers unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score for pain in the affected area;SF-36 Health Survey Summary; | — |
Secondary
| Measure | Time frame |
|---|---|
| EQ - 5 d scale;Use of NSAID (Dosage and Duration);The pain began to ease;Pain relief time;Resurrection of range of motion;Primary types of joint pain;The occurrence of contact dermatitis;Incidence of adverse events; | — |
Countries
China
Contacts
Peking Union Medical College Hospital